Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 7 studies | 26% ± 8% | |
| GABAergic neuron | 6 studies | 31% ± 13% | |
| podocyte | 5 studies | 52% ± 26% | |
| interneuron | 5 studies | 37% ± 21% | |
| endothelial cell | 4 studies | 32% ± 10% | |
| glutamatergic neuron | 4 studies | 22% ± 4% | |
| GABAergic interneuron | 3 studies | 21% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 26% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 513.35 | 240 / 245 | 97% | 6.53 | 486 / 502 |
| kidney | 100% | 950.91 | 89 / 89 | 77% | 3.21 | 690 / 901 |
| breast | 99% | 640.22 | 456 / 459 | 72% | 2.27 | 800 / 1118 |
| lung | 99% | 888.86 | 574 / 578 | 71% | 2.78 | 815 / 1155 |
| ovary | 100% | 1162.46 | 180 / 180 | 59% | 1.55 | 252 / 430 |
| thymus | 97% | 407.87 | 634 / 653 | 59% | 1.68 | 356 / 605 |
| adrenal gland | 89% | 297.77 | 230 / 258 | 65% | 1.66 | 150 / 230 |
| pancreas | 99% | 412.77 | 326 / 328 | 47% | 1.01 | 84 / 178 |
| skin | 78% | 296.30 | 1419 / 1809 | 60% | 2.44 | 285 / 472 |
| bladder | 95% | 1000.00 | 20 / 21 | 37% | 1.23 | 186 / 504 |
| uterus | 91% | 472.89 | 155 / 170 | 40% | 2.69 | 182 / 459 |
| stomach | 84% | 183.18 | 300 / 359 | 30% | 0.66 | 86 / 286 |
| intestine | 92% | 300.93 | 888 / 966 | 17% | 0.39 | 87 / 527 |
| spleen | 100% | 1638.18 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 996.27 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 95% | 627.32 | 762 / 803 | 0% | 0 | 0 / 0 |
| esophagus | 40% | 78.94 | 575 / 1445 | 55% | 2.16 | 100 / 183 |
| brain | 23% | 39.10 | 618 / 2642 | 28% | 0.61 | 196 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 42% | 1.55 | 19 / 45 |
| heart | 41% | 82.40 | 351 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 35% | 205.55 | 472 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 16% | 0.37 | 13 / 80 |
| liver | 1% | 1.95 | 3 / 226 | 9% | 0.23 | 36 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.64 | 2 / 29 |
| peripheral blood | 0% | 0.76 | 4 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
| GO_0051497 | Biological process | negative regulation of stress fiber assembly |
| GO_1904425 | Biological process | negative regulation of GTP binding |
| GO_0030833 | Biological process | regulation of actin filament polymerization |
| GO_0030054 | Cellular component | cell junction |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | ARHGAP28 |
| Protein name | Rho GTPase activating protein 28 Rho GTPase-activating protein 28 (Rho-type GTPase-activating protein 28) |
| Synonyms | KIAA1314 |
| Description | FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. . |
| Accessions | ENST00000262227.7 [Q9P2N2-2] Q9P2N2 J3QRC2 J3KT69 ENST00000577524.5 J3QLR3 J3QKM0 ENST00000419673.6 [Q9P2N2-5] E9PL26 ENST00000584387.1 ENST00000532996.5 [Q9P2N2-3] ENST00000532723.5 J3KTC0 ENST00000581099.5 E9PMX7 ENST00000584287.5 ENST00000583410.1 ENST00000314319.7 [Q9P2N2-5] ENST00000579689.1 ENST00000531294.5 ENST00000383472.9 [Q9P2N2-1] |
